*** Registration for Covishield-AstraZeneca vaccination now open in Bahrain | THE DAILY TRIBUNE | KINGDOM OF BAHRAIN

Registration for Covishield-AstraZeneca vaccination now open in Bahrain

TDT | Manama

The Daily Tribune – wwwnewsofbahrain.com

Health Minister HE Faeqa Saeed Al Saleh today announced that the first batch of the Covishield-AstraZeneca vaccine has been delivered today by the Indian Ambassador HE Piyush Shrivastav at the Bahrain International Exhibition and Convention Centre.

The Covishield-AstraZeneca vaccine, produced by AstraZeneca in cooperation with the University of Oxford, and manufactured by the Serum Institute of India under the name ‘Covishield’, has been approved for emergency use by the Kingdom’s National Health Regulatory Authority.

HE the Minister of Health applauded the support provided by the Indian Government in strengthening bilateral health cooperation in light of the global spread of COVID-19. In this regard, HE the Minister of Health noted that the depth of Bahraini-Indian relations has led to this increase in cooperation across various development fields.

HE Shrivastav expressed his gratitude and appreciation to the Government and citizens of the Kingdom of Bahrain for their commitment to further strengthening cooperation and affirmed India’s resolve to continue bolstering joint health cooperation to benefit both countries and their peoples.

The Health Ministry announced those wishing to take the Covishield-AstraZeneca vaccine can register via either the “BeAware” application or the Ministry of Health’s website on https://healthalert.gov.bh.

The Ministry explained that upon registration, individuals will be contacted via SMS message with details of their appointment for the first dose of the vaccination. It is worth noting that two doses are required for the Covishield-AstraZeneca vaccine, 28 days apart.

The Ministry of Health concluded by highlighting the National Vaccination Campaign’s commitment to providing a COVID-19 vaccine to all members of society, under the supervision and follow-up of the National Medical Taskforce for Combatting the Coronavirus (COVID-19) and its ongoing efforts to combat the virus.